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ABSTRACT
Background Clinical decision support systems
(CDSS) have the potential to improve adherence
to guidelines, but only if they are designed to work
in the complex environment of ambulatory clinics
as otherwise physicians may not use them.
Objective To gain input from primary care phys-
icians in designing a CDSS for smoking cessation to
ensure that the design is appropriate to a clinical
environment before attempts to test this CDSS in a
clinical trial. This approach is of general interest to
those designing similar systems.
Design and approach We employed an iterative
ethnographic process that used multiple evaluation
methods to understand physician preferences and
workﬂow integration. Using results from our prior
survey of physicians and clinic managers, we devel-
oped a prototype CDSS, validated content and design
with an expert panel, and then subjected it to
usability testing by physicians, followed by iterative
design changes based on their feedback. We then
performed clinical testing with individual patients,
and conducted ﬁeld tests of the CDSS in two
primary care clinics during which four physicians
used it for routine patient visits.
Results The CDSS prototype was substantially
modiﬁed through these cycles of usability and clin-
ical testing, including removing a potentially fatal
design ﬂaw. During ﬁeld tests in primary care clinics,
physicians incorporated the ﬁnal CDSS prototype
into their workﬂow, and used it to assist in smoking
cessation interventions up to eight times daily.
Conclusions A multi-method evaluation process
utilising primary care physicians proved useful for
developing a CDSS that was acceptable to phys-
icians and patients, and feasible to use in their
clinical environment.
Keywords: medical informatics, qualitative re-
search, smoking cessation
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Introduction
Computer-mediated clinical decision support systems
(CDSSs) are software systems that match characteristics
of a patient with a knowledge base of information on
recommended care in order to provide patient-speciﬁc
recommendations as well as other information man-
agement services.1–7 A number of CDSSs intended to
support the use of clinical guidelines have improved
physician adherence to guidelines, but others have
been unsuccessful.1,2,8,9
To be successful, a CDSS must work within the
complex environment of ambulatory clinics where this
technology interacts dynamically with clinicians, patients
and existing oﬃce systems.10,11 Workﬂow integration
is one of the grand challenges for health information
technology. If physicians ﬁnd these tools too diﬃcult
to incorporate into clinical workﬂow they will be aban-
doned.12–14 To avoid such problems, a CDSS should
ﬁrst reﬂect the needs and preferences of the users (e.g.
physicians) and the organisational systems (e.g. am-
bulatory clinics) within which it works.10,14–17 Such a
CDSS should then be introduced into clinical practice
only after a ‘rigorous schedule of iterative usability
testing and formative evaluation’10 during which the
CDSS is modiﬁed to reﬂect the needs of the user and
the demands of the clinical environment.
We followed these recommendations during devel-
opment of a CDSS to assist physicians in using the
United States Public Health Service (USPHS) Guideline
on Tobacco Use and Dependence Treatment. This
guideline recommends physicians perform the ﬁve
‘As’:
1 identify patients’ smoking status (‘ask’)
2 advise those who smoke to quit
3 assess readiness to quit
4 assist in quit attempts and
5 arrange for follow up.18
A CDSS for this guideline could guide physicians in
choosing and prescribing pharmacotherapy, facilitate
referral of patients to counselling resources and pro-
vide for patients a tailored handout with this informa-
tion, potentially improving adherence and eﬀectiveness
and saving time.
We employed the three-phase development process
of deﬁnition, usability testing, andclinical testing recom-
mended by Wyatt and Spiegelhalter (Figure 1).19 This
process used a multi-method ethnographic approach20
that included surveys of key stakeholders, iterative
usability testing with primary care physicians, validity
testing and consultation with an expert panel, initial
clinical testing with patients, and then pilot testing by
physicians.10,21,22
In the deﬁnition phase we surveyed 600 Vermont
primary care and subspecialty physicians and 93 clinic
oﬃce managers to determine current practice, the
environment within these ambulatory clinics, percep-
tions of barriers to performing smoking cessation
interventions and preferences among potential infor-
mation management services.4,23 This paper describes
the second and third phases of iterative design and
testing of the CDSS, including initial clinical testing
that demonstrated it was feasible for physicians to use
this CDSS in two primary care clinics.
Methods
Iterative usability and validity testing
The initial prototypewas developed by the Yale Center
for Medical Informatics based on the responses to the
surveys,23 on the smoking cessation resources in
Vermont and neighbouring states and on the content
of the USPHS Guideline.18 The purpose of the second
phase was formative evaluation of the evolving CDSS.
Figure 1 A depiction of the process used to develop the tobacco use treatment computer-mediated decision
support system (CDSS)
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Our evaluation was guided by two theories relevant to
developing information technology that favor adop-
tion by users: the TechnologyAcceptanceModel 2 and
Rogers’ Diﬀusion of Innovations.24,25 Semi-structured
interview items were constructed to address the fol-
lowing attributes from these two theories of the CDSS
as viewed by the physicians:
. perceived usefulness including job relevance and
the quality of output
. relative advantage over their current smoking cess-
ation interventions
. compatibility with clinic systems
. perceived complexity of the CDSS compared to
other information technology and their
. intention to use the CDSS if it were available.
Because the small number of participants wouldmake
valid analyses diﬃcult, we chose not to utilise quanti-
tativemeasuresof theseperceptions.Qualitativemethods
were chosen to complement our prior surveys and to
providemore rich, in-depth and nuanced information
than a quantitative questionnaire could provide.
Physician panels for usability testing
The working prototype was ﬁrst subjected to usability
testingwith threephysicians active in the tobacco control
community. In the second round of testing, four
physicians were randomly selected from a list of primary
care physicians in Chittenden County, Vermont. All
seven physicians invited to participate agreed to do so.
Usability testing consisted of each physician using the
CDSS during hypothetical patient encounters presented
by a test monitor (SC) while an observer (TWM)
recorded the interactions. The testing combined three
sources of data:
1 a think-aloud protocol
2 handwritten ﬁeld notes during observation
3 audio taped ethnographic interviews that included
the items derived from the two theories described
above.26
These interviews and observations were analysed by
two of the investigators (TWM and SC) using codes
based on the two theories. Validity was addressed by
reviewing our conclusions with the participants,27,28
by discussing results with expert panel members and
by having one investigator (BK), who was not present
at these sessions, review data analysis and interpret-
ation. Following these analyses, we developed a list of
design changes that were then incorporated into the
revised CDSS used in the next round of usability
testing.
Expert panel
We formed an expert panel consisting of three experts
on tobacco use treatment, one each in behavioural
counselling, pharmacotherapy and patient education,
and an additional physician with expertise in ambu-
latory clinic processes. These individuals reviewed the
CDSS’s validity as an implementation of the USPHS
Guideline and provided guidance on the content and
redesign of the CDSS throughout this process.We also
consulted with additional individuals who had exper-
tise in clinic information systems, Vermont’s tobacco
use cessation services, readability of patient handouts
andMedicare billing documentation and compliance.
Clinical testing
Testing with patients
The initial clinical testing of the modiﬁed CDSS was
performed in the ambulatory clinic of one of the
investigators (TWM). Once technical issues of trans-
ferring administrative data to the CDSS and printing
accurate documents were resolved, the investigator used
the CDSS with consenting patients identiﬁed through
the clinic’s standard screening process as current or
recent (within one month) smokers. Attempts were
then made to interview these patients by telephone
within two weeks of this visit to assess the patients’
perceptions of the encounter and the CDSS.
Field tests in primary care clinics
Two physicians and the staﬀ in each of two primary
care clinics agreed to ﬁeld test the CDSS. These two
clinics were selected because they were not involved in
any other current outpatient research studies and they
used a common patient administrative database pro-
gram (GE Healthcare). At the end of the testing, each
physician was interviewed separately by TWMusing a
semi-structured interview guide based on the same
items as those in the usability testing. The interview
was audio taped for transcription and review. The
protocols for the usability and clinical testing were
reviewed and approved by the University of Vermont’s
Institutional Review Board.
Results
Phase 2: iterative usability testing
In our 2003 surveys, we found that 94% of the clinics
had a computerised registration system, but only 20%
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of Vermont ambulatory clinics had an electronic health
record (EHR) into which a CDSS could be integrated,23
similar to a contemporary national estimate.29 There-
fore, a CDSS intended for wide adoption would need
to function in oﬃces in which physicians might not
otherwise use a computer during patient visits. How-
ever, the CDSS could potentially utilise information
from a computerised administrative database. Both
physicians and clinic oﬃce managers preferred that
the CDSS be on a handheld computer (PDA) for both
space and cost considerations23 and both groups
wanted the CDSS to:
1 provide patient-speciﬁc information
2 generate tailored patient handouts
3 utilise state of residence and type of health insur-
ance in forming recommendations and
4 document the intervention for the medical record.23
The initial prototype of our smoking cessation PDA
decision support system (SC-PDA) and all subsequent
prototypes of this CDSS used a web browser on a PDA
to connect via a wireless local area network to a server
in a ‘client–server’ relationship. Each day, a software
routine on the server pulled a ﬂat ﬁle of data on
scheduled patients from the administrative database
that included the primary physician, insurance cover-
age, medical record number, date of birth and resi-
dence. The server also contained the CDSS algorithms
based on theUSPHSGuideline18 and information about
local cessation resources. Based on input by the physi-
cian on the PDA screens during the patient–physician
interaction, the server compiled and printed documents
at the checkout station with information speciﬁc to
the patient.30 Figure 2 provides a schematic of the
prototype system used in the clinical testing and
Figure 3 shows examples of two of the screens.
Prior research demonstrated that an active prompt
to use a CDSSwasmore eﬀective than a passive system
relying on a physician to remember to use the sys-
tem.1,2 We, therefore, designed the ﬁrst prototype so
that the vital signs and smoking status were recorded
on a computer at intake and then communicated via
the network to the physician’s PDA as an electronic
prompt that would alert the physician to consider
using the SC-PDA.
All seven physicians who used the SC-PDA in simu-
lated clinical encounters provided numerous sugges-
tions for improvements or alterations. We modiﬁed
the SC-PDA in response to this feedback and that of
the expert panel as summarised in Table 1.
For illustrative purposes, we review the process that
led to a major revision in the SC-PDA: changing the
electronic alert to a paper-based prompt to use the SC-
PDA. Two of three physicians in Round 1 of usability
testing had negative opinions about the electronic
alert. Without an EHR in the clinic they saw no value
in entering vital signs electronically other than for the
sole purpose of identifying smoking status, and viewed
this process as interfering with current systems for
patient intake. To gauge preferences, in the second round
of usability testing we presented both the electronic
alert and an alternative paper-based prompt for using
Figure 2 A schematic of the ﬁnal prototype that was tested in the clinical testing. Stickers on the clinic vital
sign recordwouldprompt thephysician touse the SC-PDAwith appropriatepatients basedon smoking status.
The server acted as a central repository for patient administrative data and guideline information. The
physician communicatedwith this server over awireless network via aPDA fromwhichadditional information
could be entered about the patient and through which information about patient-speciﬁc guideline
recommendations and resourceswere displayed. The server compiled and printed patient speciﬁc documents
based on these data elements
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the SC-PDA. The alternative method retained the
transfer of patient administrative data to the physician’s
PDA, but not the vital signs or smoking status. Instead,
the clinic’s existing vital signs record was adapted to
indicate the smoking status by a coloured sticker that
could alert the physician to open the SC-PDA pro-
gram, select the speciﬁc patient from their roster,
conﬁrm the smoking status and then proceed with
the intervention. Three of four primary care physicians
preferred the paper-based visual prompt because it
required the least change in their clinic intake system.
The fourth physician did not like either version because
it was his opinion that asking about smoking status
every visit would alienate patients. Based on themajority
Figure 3 Examples of two of the screens on the PDAwith which the physician interacts on the SC-PDA. In the
screen on the left, the physician would determine and then check any of the boxes corresponding to some of
the factors that would be cautions or contraindications to the use of one or more FDA approvedmedications
for smoking cessation. The screen on the right would then display the recommended medications in green
(light grey in theﬁgure) and any cautionedor contraindicatedmedications in yellowor red (dark grey). In this
example, Bupropion is contraindicated because of the risk of lowering seizure threshold in patients with a
prior history of seizures or head injury
Table 1 Major design changes in the SC-PDA resulting from usability testing
Problem noted Design alterations
1 Electronic alert to use SC-PDA with appropriate
patients incompatible with clinic workﬂow and
systems
Alternative paper-based visual prompt on vital signs
sheet tested with physicians and then substituted
2 Time to obtain health history to review for
medication cautions/contraindications viewed as
excessive
Nicotine nasal spray deleted from medication
choices to reduce number of screened conditions
Two-stage screening to exclude common
contraindications to initial medication use ﬁrst
(pregnant, unstable angina, serious arrhythmia)
3 Unable to cycle from ‘not motivated’ to
‘motivated’ if patient changes intention to quit
during counselling
Button on screen recycles user back to ‘Assess’
readiness to consider quit attempt
4 Insuﬃcient counselling guidance Optional screen with prompts allows MD to
provide more counselling if desired
5 Layout of tailored handouts not inviting;
language at too high a reading level
Tailored handout scripts reviewed and edited by
education and readability consultants
6 Need health record documentation that supports
Medicare billing
The documentation note was redesigned to supplement
the standard documentation of the visit and to
comply with requirements for billing for tobacco
cessation counselling
TWMarcy, B Kaplan, SW Connolly et al106
responses, we changed to the paper-based visual prompt
in the subsequent prototype.
Phase 3: clinical testing
Testing with patients
Nine patients (three female; six male) were recruited
to have one investigator, a physician, use the CDSS
with them. Seven of the patients were current smokers
and two were recent quitters. The sequence of screens
appropriate for each patient’s smoking status and
treatment preferences was completed in an average
time of ten minutes (range 8–13 minutes). All but one
of the nine patients actively looked at the PDA screens
with the physician during the process. Five of the nine
completed a structured telephone interview with
another investigator (SC) within two weeks of the
visit; one declined the interview, one did not recall the
SC-PDA, and twowere unable to be contacted. Four of
the ﬁve interviewed patients rated the SC-PDA posi-
tively on its usefulness in assisting the discussion on
smoking; the other patient was neutral and none had
any negative comments about the SC-PDA or having
the physician use it with them. Some stated that being
able to follow the PDA screens made the questions
easier to understand and facilitated their decision-
making. Several designproblemswerediscoveredduring
this phase of the testing, and the subsequent design
changes are outlined in Table 2.
Field tests in primary care clinics
Neither of the two participating clinics had a system
for identifying a patient’s smoking status.Working with
the clinic staﬀ, the process of obtaining and recording
vital signs was adapted to include determination of
smoking status by intake personnel and using stickers
to indicate this status on the vital sign sheet. This
process was implemented before any further changes
were made so that adjusting to this system would be
less likely to aﬀect SC-PDA testing. After two weeks,
physicians were each given a PDA and trained on the
SC-PDA program in one session of approximately 60
minutes. Clinic personnel were trained on the hand-
ling of the tailored patient handouts, fax referral forms
and chart documentation notes. The participating
physicians used the SC-PDA during a trial period of
three weeks. Each physician’s assigned PDA only dis-
played the patients on his or her own schedule. An
additional entry labelled ‘generic’ allowed the program
to be used with unscheduled patients, though without
the beneﬁt of the administrative information.
The ﬁeld tests in the two clinics were completed as
scheduled except for a single day when the SC-PDA
was inoperative because of a servermalfunction. In the
physician interviews following the trial periods, the
frequency of use of the SC-PDA estimated by each of
the four physicians ranged between only four times in
three weeks to as many as eight times in one day out of
18–20daily patient visits,with themost cited frequencies
as one and four times a day. The physician using the
Table 2 Design alterations adopted after initial clinical testing with patients
Problem noted Design alterations
1 In recent quitters, no ability to increase dosage
to address signiﬁcant withdrawal symptoms
SC-PDA changed to allow physician to choose
appropriate dose of nicotine products based on
withdrawal symptoms
2 Prescription instructions not available at the end
of the SC-PDA algorithm when most physicians
write prescriptions
Last screen of the algorithm for each patient
provides prescription instructions for
recommended medications if any selected
3 If nicotine inhaler selected, physician needed to
be prompted to write a script
Pop-up screen added to remind physician that the
inhaler is not over the counter and requires a script
4 Printing order of medication instructions did
not follow recommendations if two selected
In some patients, nicotine patch is ﬁrst medication
initiated, with addition of lozenge or gum only if
continued strong urges. Order of medication
instructions changed to correspond with this usual
sequence
5 Names of several of the MAO inhibitors
unfamiliar to physicians as they checked for
this contraindication to Bupropion use
Information button allows physicians to review
generic and brand names of medications with this
property while in screen to review medical history
cautions and contraindications to speciﬁc
medication use
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SC-PDA the least stated that he had few opportunities
as there were few active smokers in his panel of patients.
The clinic support staﬀ corroborated the frequency of
use of the SC-PDA based on their handling of the
patient tailored handouts distributed at checkout.
Two of the physicians reported that the ability to
show the screens to the patient and have them ‘rally
around’ the computer and follow along with the steps
of making recommendations was a relative advantage
of the SC-PDA over standard counselling.
‘... so it was sort of a diﬀerent approach. Was not just a
provider saying ‘‘look, I want you to quit’’. It was a
provider saying, ‘‘I want you to quit and we have this
program that we’re using that could really maximize your
chances at success’’.’ (Physician 1)
All four physicians commented favourably on the
ability to personalise both the spoken and written
counselling, check for medication cautions and contra-
indications, and document their services to support
billing as well as insurance coverage of medications.
The two physicians in the ﬁrst trial clinic found the
time required to use the SC-PDA was a relative dis-
advantage. With probing, we learned to reduce user
time by emphasising during training that the SC-PDA
could print a tailored handout even if physicians chose
not to do the intervention and that physicians could
skip the quit date screen if they preferred. Prior to the
trial in the second clinic, we adapted the training to
highlight these options and eliminated a counselling
selection screen. The two physicians in the second trial
clinic both reported that they could use the SC-PDA
eﬃciently. The physician in this clinic who used it the
most stated;
‘It actually is pretty quick and easy. I suspect that most of
my interventions were in the lower end of three to ten
minutes.’ (Physician 4)
This physician also commented that she would tend to
bill for the service when using the SC-PDA, whereas
before she had not, partially compensating for the
additional time spent. Notably this physician had not
previously used a PDA.
Discussion
We developed a CDSS for smoking cessation inter-
ventions hand-in-handwith physicians – the intended
endusers.Weused an ethnographic approach in order
to design a CDSS that provided advantages over how
physicians usually advise patients about smoking, that
was compatible with clinic workﬂow, and that was inte-
grated with how physicians conduct patient visits.14,21
Through usability testing, we were better able to
understand the workﬂow of the clinical practice, trans-
late these preferences into the design of our SC-PDA
and then implement the SC-PDA in two ambulatory
clinics. This experience illustrates the value of a staged
multi-method ethnographic process for obtaining
detailed end user feedback during the development
of health information technology.
For example, we ﬁrst incorporated an electronic
alert into the prototype SC-PDA because this charac-
teristic had been associated in the literature with im-
provements in physician adherence. Usability testing
demonstrated, however, that physicians were resistant
to a diﬀerent method of identifying smoking status
because of its perceived impact on existing oﬃce sys-
tems. This opinion was not apparent in our surveys of
physicians and clinic managers. Had we retained the
electronic alert, we could have experienced multiple
failed attempts during implementation. Additional
problems with the SC-PDA became apparent only
when using it with patients in the clinical setting.
Our pilot tests in two clinics demonstrated that
physicians did use the ﬁnal SC-PDA prototype in actual
clinical settings, and did see a relative advantage of the
SC-PDA over usual practice. The time required to use
the SC-PDA is a recognised barrier to preventive care
in general and tobacco counselling in particular.31,32
We took several measures to address this in our design.
First, additional information about medications and
counsellingwas provided in screens that were available if
desired, but it was not necessary to work through
these. Second, we acted on physician recommendations
to streamline information and reduce the content and
number of screens. Third, the SC-PDA could produce a
tailored handout for a patient even if the physician
opted not to use the intervention during a patient visit.
An unanticipated observation was that both patients
and physicians saw beneﬁts in having the patient view
the screens along with the physician. This shared
viewing of screen contents engaged the patient and
appeared to improve patient understanding. A CDSS
designed for patients to use by themselves would not
capitalise on this interaction. The future development
of decision support systems should exploit a CDSS’s
potential for interactive, collaborative decision making.
There are limitations to this approach to CDSS
development. The time-intensive nature of usability
testing reduces the number of end users who can
provide feedback. Those who accept an invitation to
do usability testing may not be representative of other
physicians. In addition, a CDSS developed through
this process still may not increase guideline adherence
or improve patient outcomes even if physicians use
the CDSS. Clinical trials are necessary to address these
questions. However, this type of CDSS development
should precede any large-scale testing to avoid ex-
pensive null results from a CDSS that physicians will
not use during these clinical trials.
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A particular limitation to ourmethods was that one
of the developers (TWM) recruited the physicians and
clinics selected for usability testing and was present
during the usability testing.However, other evaluators
(SC and BK) were not involved in the SC-PDA devel-
opment. Wears et al recommend that the developers
of a health information technology system should not
be the evaluators of the system as there is the potential
for bias.11 The developer/evaluator may selectively
record criticisms and the subjects may be less open
with the developer about problems they perceive.
Conclusions
Successful integration of health information tech-
nology into clinical practice will require collaborative
development of these systems with physicians, patients
and support staﬀ. The combination of multiple and
iterative ethnographic methods incorporating surveys,
usability testing and expert panels is feasible and
useful. Through this process we avoided costly and
potentially fatal errors in the design of our CDSS.
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